Anbio Biotechnology Class Stock Price Prediction
| NNNN Stock | 33.50 2.34 6.53% |
Momentum 51
Impartial
Oversold | Overbought |
Quarterly Revenue Growth (0.36) |
Using Anbio Biotechnology hype-based prediction, you can estimate the value of Anbio Biotechnology Class from the perspective of Anbio Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Anbio Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Anbio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Anbio Biotechnology after-hype prediction price | USD 32.65 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections. Anbio Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Anbio Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anbio Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anbio Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anbio Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Anbio Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anbio Biotechnology's historical news coverage. Anbio Biotechnology's after-hype downside and upside margins for the prediction period are 19.41 and 45.89, respectively. We have considered Anbio Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anbio Biotechnology is slightly risky at this time. Analysis and calculation of next after-hype price of Anbio Biotechnology Class is based on 3 months time horizon.
Anbio Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Anbio Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anbio Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anbio Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.64 | 13.24 | 0.85 | 0.01 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
33.50 | 32.65 | 2.54 |
|
Anbio Biotechnology Hype Timeline
Anbio Biotechnology Class is now traded for 33.50. The entity has historical hype elasticity of -0.85, and average elasticity to hype of competition of 0.01. Anbio is estimated to decline in value after the next headline, with the price expected to drop to 32.65. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.54%, whereas the daily expected return is now at 0.64%. The volatility of related hype on Anbio Biotechnology is about 120363.64%, with the expected price after the next announcement by competition of 33.51. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 4 days. Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections.Anbio Biotechnology Related Hype Analysis
Having access to credible news sources related to Anbio Biotechnology's direct competition is more important than ever and may enhance your ability to predict Anbio Biotechnology's future price movements. Getting to know how Anbio Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anbio Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ANGO | AngioDynamics | 0.09 | 9 per month | 1.53 | 0.12 | 4.00 | (2.84) | 10.17 | |
| TALK | Talkspace | 0.17 | 9 per month | 2.44 | 0.14 | 4.69 | (3.97) | 18.78 | |
| CLPT | Clearpoint Neuro | (1.01) | 7 per month | 0.00 | (0.07) | 9.30 | (9.84) | 37.97 | |
| CYH | Community Health Systems | 0.07 | 9 per month | 3.28 | 0.01 | 6.12 | (6.58) | 33.46 | |
| CMPS | Compass Pathways Plc | 0.11 | 6 per month | 4.31 | 0.07 | 8.25 | (5.85) | 28.62 | |
| AVNS | Avanos Medical | (0.11) | 10 per month | 0.00 | (0.07) | 4.06 | (3.06) | 9.72 | |
| KALV | Kalvista Pharmaceuticals | 0.13 | 10 per month | 3.13 | 0.06 | 8.43 | (6.42) | 22.91 | |
| GOSS | Gossamer Bio | 0.28 | 10 per month | 5.16 | 0.03 | 9.59 | (7.02) | 31.39 | |
| RIGL | Rigel Pharmaceuticals | 0.44 | 9 per month | 3.49 | 0.11 | 7.75 | (6.40) | 44.65 | |
| SNDL | SNDL Inc | (0.06) | 8 per month | 0.00 | (0.09) | 9.94 | (6.77) | 37.98 |
Anbio Biotechnology Additional Predictive Modules
Most predictive techniques to examine Anbio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anbio using various technical indicators. When you analyze Anbio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Anbio Biotechnology Predictive Indicators
The successful prediction of Anbio Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anbio Biotechnology Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anbio Biotechnology based on analysis of Anbio Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anbio Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anbio Biotechnology's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 0.0555 | 102.5 | 47.48 | 41.83 | PTB Ratio | 66.17 | 56.03 | 14.19 | 13.48 |
Story Coverage note for Anbio Biotechnology
The number of cover stories for Anbio Biotechnology depends on current market conditions and Anbio Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Anbio Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Anbio Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Anbio Biotechnology Short Properties
Anbio Biotechnology's future price predictability will typically decrease when Anbio Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Anbio Biotechnology Class often depends not only on the future outlook of the potential Anbio Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anbio Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.3 M | |
| Cash And Short Term Investments | 11.8 M |
Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.05 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anbio Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.